NRx Pharmaceuticals, Inc. (NRXP) has a market capitalization of $43.56M and trades at $2.52. The 52-week range is 1.58-3.84.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -1.9, Earnings Per Share (EPS) of $-1.34, annual revenue of $1.23M.
The stock has a beta of 1.83, operates in the Healthcare sector.
